News

TRiCares Announces Successful First in Human Implantations of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System

Details

TRiCares SAS (“TRiCares”), today is pleased to announce the successful first in human implantations of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”). 

Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

Details

Quanta announced that it has raised $245 million in an oversubscribed and upsized Series D round, the largest private funding round for a dialysis device company in history.  

CARISMA Therapeutics Appoints Richard Morris as Chief Financial Officer

Details

CARISMA Therapeutics, announced that Richard Morris has been appointed Chief Financial Officer (CFO). 

  1. ONWARD Completes $32 Million Financing Round
  2. Clinical Data with ImCheck’s ICT01 to be Presented at AACR: Positive Results Observed on Safety, Activation of Gamma 9 Delta 2 T Cells and Anti-tumor Immune Response
  3. UroMems Completes €23 Million Series B Financing
  4. Immatics Presents Data Update on Dose Escalation from Ongoing ACTengine® Cell Therapy Programs
© Wellington Partners, 2021.